Details of the Drug Reposition

General Information of This Drug (ID: DM6GB6B)

Drug Name	BMS-241027 DM6GB6B

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Tauopathy	DISY2IPA	6D85.Y	Phase 1	[1]
Alzheimer disease	DISF8S70	8A20	Phase 1	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01492374) Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease. U.S. National Institutes of Health.